SARS and MERS: recent insights into emerging coronaviruses

de Wit, Emmie, van Doremalen, Neeltje, Falzarano, Darryl, Munster, Vincent J.·2016·Nature Reviews Microbiology
DOI 10.1038/nrmicro.2016.81

Cited by (1,002)

Items 801–900 of 1,002

  1. Neurological manifestations in patients with COVID‐19: A systematic review and meta‐analysis
    Marzie Mahdizade Ari, Mohamad Hosein Mohamadi, Negar Shadab Mehr, Sajjad Abbasimoghaddam, Amirhosein Shekartabar, Mohsen Heidary, Saeed Khoshnood · 2022 · Journal of Clinical Laboratory Analysis
  2. Azithromycin through the Lens of the COVID-19 Treatment
    Georgia G. Kournoutou, George P. Dinos · 2022 · Antibiotics
  3. Immune evasion of neutralizing antibodies by SARS-CoV-2 Omicron
    Lidong Wang, Michelle Møhlenberg, Pengfei Wang, Hao Zhou · 2023 · Cytokine & Growth Factor Reviews
  4. Liposomes – A Novel Drug Delivery System
    Ammaarah, Krishna Sailaja A · 2020 · South Asian Research Journal of Pharmaceutical Sciences
  5. Identification of diverse viruses in upper respiratory samples in dromedary camels from United Arab Emirates
    Yan Li, Abdelmalik Ibrahim Khalafalla, Clinton R. Paden, Mohammed Farouk Yusof, Yassir Mohammed Eltahir, Zulaikha Mohamed Abdel Hameed Al Hammadi, Ying Tao, Krista J. Queen, Farida Ismail Al Hosani, Susan I. Gerber et al. · 2017 · PLoS ONE
  6. Interferon Regulatory Factor 3-Mediated Signaling Limits Middle-East Respiratory Syndrome (MERS) Coronavirus Propagation in Cells from an Insectivorous Bat
    Arinjay Banerjee, Darryl Falzarano, Noreen Rapin, Jocelyne M. Lew, Vikram Misra · 2019 · Viruses
  7. Crystal Structure of African Swine Fever Virus pS273R Protease and Implications for Inhibitor Design
    Guobang Li, Xiaoxia Liu, Mengyuan Yang, Guangshun Zhang, Zhengyang Wang, Kun Guo, Yuxue Gao, Peng Jiao, Jixue Sun, Cheng Chen et al. · 2020 · Journal of Virology
  8. Repurposed Drugs, Molecular Vaccines, Immune‐Modulators, and Nanotherapeutics to Treat and Prevent COVID‐19 Associated with SARS‐CoV‐2, a Deadly Nanovector
    Taru Dube, Amrito Ghosh, Jibanananda Mishra, Uday B. Kompella, Jiban Jyoti Panda · 2020 · Advanced Therapeutics
  9. Pathology of Coronavirus Infections: A Review of Lesions in Animals in the One-Health Perspective
    Valentina Zappulli, Silvia Ferro, Federico Bonsembiante, Ginevra Brocca, Alessandro Calore, Laura Cavicchioli, Cinzia Centelleghe, Giorgia Corazzola, Steffen De Vreese, Maria Elena Gelain et al. · 2020 · Animals
  10. Fluoroquinolone Antibiotics Exhibit Low Antiviral Activity against SARS-CoV-2 and MERS-CoV
    Stacey L. P. Scroggs, Danielle K. Offerdahl, Dylan P. Flather, Ciera N Morris, Benjamin Luke Kendall, Rebecca M. Broeckel, Paul A. Beare, Marshall E. Bloom · 2020 · Viruses
  11. Targeting inflammatory cytokine storm to fight against COVID-19 associated severe complications
    Rishabh Hirawat, Mohd Aslam Saifi, Chandraiah Godugu · 2020 · Life Sciences
  12. Treatment profiles and clinical outcomes of COVID-19 patients at private hospital in Jakarta
    Diana Laila Ramatillah, Suri Isnaini · 2021 · PLoS ONE
  13. Early Epidemiological Features of COVID-19 in Nepal and Public Health Response
    S. Dhakal, S. Karki · 2020 · Frontiers in Medicine
  14. Site mapping and small molecule blind docking reveal a possible target site on the SARS-CoV-2 main protease dimer interface
    Julia J. Liang, Chris Karagiannis, Eleni Pitsillou, Kevion K. Darmawan, Ken Ng, Andrew Hung, Tom C. Karagiannis · 2020 · Computational Biology and Chemistry
  15. Utility of Proteomics in Emerging and Re-Emerging Infectious Diseases Caused by RNA Viruses
    Maike Sperk, Robert van Domselaar, Jimmy Rodriguez Murillo, Flora Mikaeloff, Beatriz Sá Vinhas, Elisa Saccon, Anders B. Sönnerborg, Kamal Deep Singh, Soham Gupta, Ákos Végvári et al. · 2020 · Journal of Proteome Research
  16. Role of Inflammation in Virus Pathogenesis during Pregnancy
    Anna Chudnovets, Jin Liu, Harish Narasimhan, Yang Liu, Irina D. Burd · 2020 · Journal of Virology
  17. Multiple Expression Assessments of ACE2 and TMPRSS2 SARS-CoV-2 Entry Molecules in the Urinary Tract and Their Associations with Clinical Manifestations of COVID-19
    Xiaohan Ren, Xiyi Wei, Guangyao Li, Shancheng Ren, Xu Chen, Tongtong Zhang, Tongtong Zhang, Zhongwen Lu, Zhongwen Lü, Shangqian Wang et al. · 2020 · Infection and Drug Resistance
  18. Structure and regulation of coronavirus genomes: state-of-the-art and novel insights from SARS-CoV-2 studies
    Ilaria Manfredonia, Danny Incarnato · 2020 · Biochemical Society Transactions
  19. Lactiplantibacillus plantarum as a Potential Adjuvant and Delivery System for the Development of SARS-CoV-2 Oral Vaccines
    Julio Villena, Chang Li, María Guadalupe Vizoso-Pinto, Jacinto Sacur, Linzhu Ren, Haruki Kitazawa · 2021 · Microorganisms
  20. Preclinical evaluation of Imatinib does not support its use as an antiviral drug against SARS-CoV-2
    Franck Touret, Jean‐Sélim Driouich, Maxime Cochin, Paul-Rémi Petit, Magali Gilles, Karine Barthélémy, Grégory Moureau, François‐Xavier Mahon, Denis J.-M. Malvy, Caroline Solas et al. · 2021 · Antiviral Research
  21. Common Inflammatory Mechanisms in COVID-19 and Parkinson’s Diseases: The Role of Microbiome, Pharmabiotics and Postbiotics in Their Prevention
    Valery Danilenko, Andrey Devyatkin, Mariya Marsova, Madina Shibilova, Rustem Abuzarovich Ilyasov, Vladimir Shmyrev · 2021 · Journal of Inflammation Research
  22. Spike protein of SARS-CoV-2 variants: a brief review and practical implications
    Kattlyn Laryssa Candido, Caio Ricardo Eich, Luciana Oliveira de Fariña, Marina Kimiko Kadowaki, José Luis da Conceição Silva, Alexandre Maller, Rita de Cássia Garcia Simão · 2022 · Brazilian Journal of Microbiology
  23. Corrigendum: Identification of Diverse Bat Alphacoronaviruses and Betacoronaviruses in China Provides New Insights Into the Evolution and Origin of Coronavirus-Related Diseases
    Yelin Han, Jiang Du, Haoxiang Su, Junpeng Zhang, Guangjian Zhu, Shuyi Y. Zhang, Zhìqiáng Wú, Qi Jin · 2020 · Frontiers in Microbiology
  24. SARS-CoV-2 Infection of Ocular Cells from Human Adult Donor Eyes and hESC-Derived Eye Organoids
    Bar Makovoz, Rasmus Møeller, Anne Zebitz Eriksen, Benjamin Robert tenOever, Timothy A. Blenkinsop · 2020 · SSRN Electronic Journal
  25. Broad-Spectrum Coronavirus Fusion Inhibitors to Combat COVID-19 and Other Emerging Coronavirus Diseases
    Xinling Wang, Shuai Xia, Qian Wang, Wei Xu, Weihua Li, Lu Lu, Shibo Jiang · 2020 · International Journal of Molecular Sciences
  26. SciSight: Combining faceted navigation and research group detection for COVID-19 exploratory scientific search
    Tom Hope, Jason Portenoy, Kishore Vasan, Jonathan Borchardt, Eric Horvitz, Daniel S. Weld, Marti A. Hearst, Jevin D. West · 2020 · Conference on Empirical Methods in Natural Language Processing: System Demonstrations (EMNLP)
  27. Predictive factors of severe coronavirus disease 2019 in previously healthy young adults: a single-center, retrospective study
    Changzhi Zhou, Zhe Huang, Weijun Tan, Xueying Li, Wen Yin, Yang Xiao, Zhaowu Tao, Shuang Geng, Yi Hu · 2020 · Respiratory Research
  28. New Caputo-Fabrizio fractional order SEIAS q E q HR model for COVID-19 epidemic transmission with genetic algorithm based control strategy
    M. Higazy, Maryam Ahmed Alyami · 2020 · Alexandria Engineering Journal
  29. In vivo imaging of the pathophysiological changes and neutrophil dynamics in influenza virus-infected mouse lungs
    Hiroshi Ueki, I-Hsuan Wang, Satoshi Fukuyama, Hiroaki Katsura, Tiago José da Silva Lopes, Gabriele Neumann, Yoshihiro Kawaoka · 2018 · Proceedings of the National Academy of Sciences
  30. Clinical utility of cardiac troponin measurement in COVID-19 infection
    David C. Gaze · 2020 · Annals of Clinical Biochemistry International Journal of Laboratory Medicine
  31. Genomic analysis and comparative multiple sequences of SARS-CoV2
    Tai-Jay Chang, De‐Ming Yang, Mong‐Lien Wang, Kung-How Liang, Ping‐Hsing Tsai, Shih-Hwa Chiou, Ta‐Hsien Lin, Chin-Tien Wang · 2020 · Journal of the Chinese Medical Association
  32. COVID-19 : physiopathologie d’une maladie à plusieurs visages
    Vincent Bonny, Alexis Maillard, Cyril Mousseaux, Léo Plaçais, Quentin Richier · 2020 · La Revue de Médecine Interne
  33. Inhibition of Human Adenovirus Replication by the Importin α/β1 Nuclear Import Inhibitor Ivermectin
    Cason R. King, Tanner M. Tessier, Mackenzie J. Dodge, Jason B. Weinberg, Joe S. Mymryk · 2020 · Journal of Virology
  34. Identification of some novel oxazine substituted 9-anilinoacridines as SARS-CoV-2 inhibitors for COVID-19 by molecular docking, free energy calculation and molecular dynamics studies
    Kalirajan Rajagopal, Potlapati Varakumar, Baliwada Aparna, Gowramma Byran, Srikanth Jupudi · 2020 · Journal of Biomolecular Structure and Dynamics
  35. Targeting Polyamines Inhibits Coronavirus Infection by Reducing Cellular Attachment and Entry
    Mason R. Firpo, Vincent Mastrodomenico, Grant M. Hawkins, Matthieu Prot, Laura Levillayer, Tom Gallagher, Etienne Simon‐Lorière, Bryan C. Mounce · 2020 · ACS Infectious Diseases
  36. A blood-based host gene expression assay for early detection of respiratory viral infection: an index-cluster prospective cohort study
    Micah T. McClain, Florica J. Constantine, Bradly P. Nicholson, Marshall Nichols, Thomas W. Burke, Ricardo Henao, Daphne C Jones, Lori L. Hudson, L. Brett Jaggers, Timothy Veldman et al. · 2020 · The Lancet Infectious Diseases
  37. Myocardial injury and risk factors for mortality in patients with COVID-19 pneumonia
    Chongtu Yang, Fen Liu, Wei Yong Liu, Guijuan Cao, Jiacheng Liu, Songjiang Huang, Muxin Zhu, Chao Tu, Jianwen Wang, Bin Xiong · 2020 · International Journal of Cardiology
  38. Prior Presumed Coronavirus Infection Reduces COVID-19 Risk: A Cohort Study
    Dvir Aran, Daniel C. Beachler, Stephan Lanes, J. Marc Overhage · 2020 · Journal of Infection
  39. Coronavirus disease-19: The multi-level, multi-faceted vasculopathy
    Thiago Quinaglia, Mahsima Shabani, Ikaro Soares Santos Breder, Harry A. Silber, João A.C. Lima, Andrei Carvalho Sposito · 2021 · Atherosclerosis
  40. Discovery of anti-MERS-CoV small covalent inhibitors through pharmacophore modeling, covalent docking and molecular dynamics simulation
    Mubarak A. Alamri, Muhammad Tahir ul Qamar, Obaid Afzal, Alhumaidi B. Alabbas, Yassine Riadi, Safar M. Alqahtani · 2021 · Journal of Molecular Liquids
  41. Gut-Lung Axis in COVID-19
    Imane Allali, Youssef Bakri, Saaïd Amzazi, Hassan Ghazal · 2021 · Interdisciplinary Perspectives on Infectious Diseases
  42. SARS-CoV-2 in animals: From potential hosts to animal models
    Anna Michelitsch, K. Wernike, Lorenz Ulrich, T. Mettenleiter, M. Beer · 2021 · Advances in Virus Research
  43. SARS-CoV-2 Membrane Glycoprotein M Triggers Apoptosis With the Assistance of Nucleocapsid Protein N in Cells
    Yujie Ren, An Wang, Yuan Fang, Ting Shu, Di Wu, Chong Wang, Muhan Huang, Juan Min, Liang Jin, Wei Zhou et al. · 2021 · Frontiers in Cellular and Infection Microbiology
  44. A digital health platform for assisting the diagnosis and monitoring of COVID-19 progression: An adjuvant approach for augmenting the antiviral response and mitigating the immune-mediated target organ damage
    Yuval Ishay, Assaf Potruch, Asaf Schwartz, Marc Berg, Khurram Jamil, Samuel Agus, Yaron Ilan · 2021 · Biomedicine & Pharmacotherapy
  45. Ultrasensitive Detection of COVID-19 Causative Virus (SARS-CoV-2) Spike Protein Using Laser Induced Graphene Field-Effect Transistor
    Tianrui Cui, Yancong Qiao, Jianwei Gao, Chunhua Wang, Yu Zhang, Lin Ge Han, Yi Yang, Tian‐Ling Ren · 2021 · Molecules
  46. Crystallization of Feline Coronavirus Mpro With GC376 Reveals Mechanism of Inhibition
    Jimmy Lu, Sizhu Amelia Chen, Muhammad Bashir Khan, Raelynn Brassard, Elena I Arutyunova, Tess Lamer, Wayne Vuong, Conrad Fischer, Howard S. Young, John C. Vederas et al. · 2022 · Frontiers in Chemistry
  47. Advances in research on 3C-like protease (3CL pro ) inhibitors against SARS-CoV-2 since 2020
    Roufen Chen, Yali Gao, Han Liu, He Li, Wen‐Fa Chen, Junjie Ma · 2022 · RSC Medicinal Chemistry
  48. Clinical characteristics of 101 COVID-19 nonsurvivors in Wuhan, China: a retrospective study
    Qiao Shi, Kailiang Zhao, Jia Yu, Fang Jiang, Jiarui Feng, Kaiping Zhao, Xiaoyi Zhang, Xiaoyan Chen, Peng Hu, Yu-pu Hong et al. · 2020 · medRxiv
  49. Cell-based therapies for coronavirus disease 2019: proper clinical investigations are essential
    Maroun Khoury, Patrícia R. M. Rocco, Donald G. Phinney, Mauro Krampera, Iván Martín, Sowmya Viswanathan, Jan A. Nolta, Katarina LeBlanc, Jacques Galipeau, Daniel J. Weiss · 2020 · Cytotherapy
  50. Current diagnostic tools for coronaviruses–From laboratory diagnosis to POC diagnosis for COVID ‐19
    Yung‐Chih Wang, Yi‐Tzu Lee, Ting Yang, Jun‐Ren Sun, Ching‐Fen Shen, Chao‐Min Cheng · 2020 · Bioengineering & Translational Medicine
  51. COVID-19: molecular and serological detection methods
    Ahmed E. Dhamad, Muna A. Abdal Rhida · 2020 · PeerJ
  52. Is there possibility of vertical transmission of COVID-19: a systematic review
    Jiajun Yuan, Qian Han, Shiyan Cao, Bin Dong, Xiaoyu Yan, Shuanghong Luo, Min Zhou, Sha Zhou, Botao Ning, Liebin Zhao · 2021 · Translational Pediatrics
  53. SARS-CoV-2 environmental contamination from hospitalised patients with COVID-19 receiving aerosol-generating procedures
    Rebecca Winslow, Jie Zhou, Ella F Windle, Intesar Nur, Ranjit Lall, Chen Ji, Jonathan Edward Millar, Paul M Dark, Jay Naisbitt, Anita Kay Simonds et al. · 2021 · Thorax
  54. Electrochemical Aptasensing of SARS-CoV-2 Based on Triangular Prism DNA Nanostructures and Dumbbell Hybridization Chain Reaction
    Yu Jiang, Xifeng Chen, Ninghan Feng, Peng Miao · 2022 · Analytical Chemistry
  55. Point‐of‐care diagnostic assay for rapid detection of porcine deltacoronavirus using the recombinase polymerase amplification method
    Lei Ma, Fanwen Zeng, Bihong Huang, Yujun Zhu, Miaoli Wu, Fengjiao Xu, Li Xiao, Ren Huang, Jingyun Ma, Feng Cong et al. · 2019 · Transboundary and Emerging Diseases
  56. Genetic diversity and ecology of coronaviruses hosted by cave-dwelling bats in Gabon
    Gaël Darren Maganga, Anaïs Pinto, Illich Manfred Mombo, Mankomra Madjitobaye, Antoine Mitte Mbeang Beyeme, Larson Boundenga, Meriadeg Ar Gouilh, Nadine N’dilimabaka, Jan Felix Drexler, Christian Drosten et al. · 2020 · Scientific Reports
  57. Coronaviridae—Old friends, new enemy!
    Jair Carneiro Leão, TERESA PAULA DE LIMA GUSMÃO, ADRIANA MACHADO ZARZAR, Jair Carneiro Leão, ANDREZA BARKOKEBAS SANTOS DE FARIA, Igor Henrique Morais Silva, Luiz Alcino Gueiros, Narendran Andrew Robinson, Stephen Ross Porter, Alessandra de Albuquerque Tavares Carvalho · 2020 · Oral Diseases
  58. An accurate, high-speed, portable bifunctional electrical detector for COVID-19
    Guojun Ke, Dingkai Su, Yu Li, Yu Zhao, Honggang Wang, Wanjian Liu, Man Li, Zhiting Yang, Fang Xiao, Yuan Yao et al. · 2020 · Science China Materials
  59. In the eye of the storm: SARS‐CoV‐2 infection and replication at the ocular surface?
    Lyle Armstrong, Joseph Collin, Islam Mostafa, Rachel A. Queen, Francisco C. Figueiredo, Majlinda Lako · 2021 · Stem Cells Translational Medicine
  60. Multistep rational molecular design and combined docking for discovery of novel classes of inhibitors of SARS-CoV-2 main protease 3CLpro
    Roman S. Tumskiy, Anastasiia V. Tumskaia · 2021 · Chemical Physics Letters
  61. Preclinical evaluation of a plant-derived SARS-CoV-2 subunit vaccine: Protective efficacy, immunogenicity, safety, and toxicity
    Balamurugan Shanmugaraj, Narach Khorattanakulchai, Chalisa Panapitakkul, Ashwini Malla, Rawiwan Im‐Erbsin, Manutsanun Inthawong, Piyanate Sunyakumthorn, Taweewun Hunsawong, Chonticha Klungthong, Matthew C. Reed et al. · 2022 · Vaccine
  62. Epidemiological characteristics and transmission model of Corona Virus Disease 2019 in China
    Dongming Wang, Min Zhou, Xiuquan Nie, Weihong Qiu, Meng Yang, Xing Wang, Tao Xu, Zi Ye, Xiaobin Feng, Yang Xiao et al. · 2020 · Journal of Infection
  63. Potential Non-Covalent SARS-CoV-2 3C-like Protease Inhibitors Designed Using Generative Deep Learning Approaches and Reviewed by Human Medicinal Chemist in Virtual Reality
    Alex A. Zhavoronkov, Bogdan A. Zagribelnyy, Alexander Zhebrak, Vladimir Aladinskiy, Victor A. Terentiev, Quentin Vanhaelen, Dmitry S. Bezrukov, Daniil A. Polykovskiy, Rim Shayakhmetov, Andrey Filimonov et al. · 2020 · ChemRxiv
  64. Fluoxetine Can Inhibit SARS-CoV-2 In Vitro
    Arthur Dechaumes, Magloire Pandoua Nekoua, Sandrine Belouzard, Famara Sané, Ilka Engelmann, Jean Dubuisson, Enagnon Kazali Alidjinou, Didier Hober · 2021 · Microorganisms
  65. Correlating qRT-PCR, dPCR and Viral Titration for the Identification and Quantification of SARS-CoV-2: A New Approach for Infection Management
    Martina Brandolini, Francesca Taddei, Maria Michela Marino, Laura Grumiro, Agata Scalcione, María Elena Turba, Fabio Gentilini, Michela Fantini, Silvia Zannoli, Giorgio Dirani et al. · 2021 · Viruses
  66. Inhaled remdesivir reduces viral burden in a nonhuman primate model of SARS-CoV-2 infection
    Meghan S. Vermillion, Eisuke Murakami, Bin Ma, Jared Pitts, Adrian Tomkinson, Davin Rautiola, Darius M. Babusis, Hammad Irshad, Dustin Seigel, Cynthia Kim et al. · 2021 · Science Translational Medicine
  67. Spotlight on therapeutic efficiency of mesenchymal stem cells in viral infections with a focus on COVID-19
    Saman Yasamineh, Hesam Ghafouri Kalajahi, Pooneh Yasamineh, Omid Gholizadeh, Hamed Rahmani Youshanlouei, Saeed Karimi Matloub, Masoud Mozafari, Elham Jokar, Yalda Yazdani, Mehdi Dadashpour · 2022 · Stem Cell Research & Therapy
  68. Impact of COVID 19 on erectile function
    Damilare Hakeem Adeyemi, Adeyemi Fatai Odetayo, Moses Agbomhere Hamed, Roland Eghoghosoa Akhigbe · 2022 · The Aging Male
  69. Evaluation of electrocardiographic ventricular repolarization variables in patients with newly diagnosed COVID-19
    Mustafa Yenerçağ, Uğur Arslan, Mustafa Doğduş, Özgür Günal, Çağatay Erman Öztürk, Gökhan Aksan, Güney Erdoğan, Sefa Gül, Osman Can Yontar, Ahmet Şen · 2020 · Journal of Electrocardiology
  70. Probing antiviral drugs against SARS-CoV-2 through virus-drug association prediction based on the KATZ method
    Liqian Zhou, Juanjuan Wang, Guangyi Liu, Qingqing Lu, Ruyi Dong, Geng Tian, Jialiang Yang, Lihong Peng · 2020 · Genomics
  71. Combined deep learning and molecular docking simulations approach identifies potentially effective FDA approved drugs for repurposing against SARS-CoV-2
    Muhammad Umer Anwaar, Farjad Adnan, Asma Abro, Rayyan Azam Khan, Asad U. Rehman, Muhammad Osama, Christopher Rainville, Suresh Kumar, David E. Sterner, Saad Javed et al. · 2021 · Computers in Biology and Medicine
  72. The Role of Molecular Chaperones in Virus Infection and Implications for Understanding and Treating COVID-19
    Letizia Paladino, Alessandra Maria Vitale, Celeste Caruso Bavisotto, Everly Conway de Macario, Francesco Cappello, Alberto J.L. Macario, Antonella Marino · 2020 · Journal of Clinical Medicine
  73. Recent advances in vaccine and immunotherapy for COVID-19
    Ali Ahmed Rabaan, Shamsah H. Al-Ahmed, Ranjit Sah, Jaffar A. Al‐Tawfiq, Ayman M. Al‐Qaaneh, Lamiaa Hamad Al-Jamea, Alexander Woodman, Manaf AlQahtani, Shafiul Haque, Harapan Harapan et al. · 2020 · Human Vaccines & Immunotherapeutics
  74. Saliva NMR-Based Metabolomics in the War Against COVID-19
    Gilson Costa dos Santos, Cláudia Maria Pereira, Tatiana Kelly da Silva Fidalgo, Ana Paula Valente · 2020 · Analytical Chemistry
  75. Identification of Potential Inhibitors of 3CL Protease of SARS-CoV-2 From ZINC Database by Molecular Docking-Based Virtual Screening
    Ashraf Ahmed Ali Abdusalam, Vikneswaran Murugaiyah · 2020 · Frontiers in Molecular Biosciences
  76. The potential use of microRNAs as a therapeutic strategy for SARS-CoV-2 infection
    Jiulue Hu, Jelena Stojanović, Saman Yasamineh, Pooneh Yasamineh, Sathish Kumar Karuppannan, Mohammed Junaid Hussain Dowlath, Hamed Serati‐Nouri · 2021 · Archives of Virology
  77. Economic and Health Impacts of Social Distancing Policies during the Coronavirus Pandemic
    Hunt Allcott, Levi Boxell, Jacob Conway, Billy Ferguson, Matthew Aaron Gentzkow, Benjamin Goldman · 2020 · SSRN Electronic Journal
  78. Insights on early mutational events in SARS-CoV-2 virus reveal founder effects across geographical regions
    Carlos Farkas, Francisco Fuentes‐Villalobos, José Luis Velasco Garrido, Jody J. Haigh, María Inés Barría · 2020 · PeerJ
  79. Alimentos, Sars-CoV-2 e Covid-19: contato possível, transmissão improvável
    Bernadette Dora Gombossy de Melo Franco, Mariza Landgraf, Uelinton Manoel Pinto · 2020 · Estudos Avançados
  80. COVID‐19 infection, progression, and vaccination: Focus on obesity and related metabolic disturbances
    Annemarie J. F. Westheim, Albert V. Bitorina, Jan Theys, Ronit Shiri‐Sverdlov · 2021 · Obesity Reviews
  81. Evolution of the SARS-CoV-2 genome and emergence of variants of concern
    Iman Safari, Elahe Elahi · 2021 · Archives of Virology
  82. Animal Models, Zoonotic Reservoirs, and Cross-Species Transmission of Emerging Human-Infecting Coronaviruses
    Yakhouba Kane, Gary Wong, George F. Gao · 2023 · Annual Review of Animal Biosciences
  83. Transmission of droplet aerosols in an elevator cabin: Effect of the ventilation mode
    Xian Li, Bujin Feng · 2023 · Building and Environment
  84. Development and Evaluation of a Multiplexed Immunoassay for Simultaneous Detection of Serum IgG Antibodies to Six Human Coronaviruses
    Suvang U. Trivedi, Congrong Miao, Joseph E. Sanchez, Hayat Caidi, Azaibi Tamin, Lia M. Haynes, Natalie J. Thornburg · 2019 · Scientific Reports
  85. Excess Soluble fms-like Tyrosine Kinase 1 Correlates With Endothelial Dysfunction and Organ Failure in Critically Ill Coronavirus Disease 2019 Patients
    Vincent Dupont, Lukshe Kanagaratnam, Antoine Goury, Gaël Poitevin, Mathieu Bard, Gauthier Julien, Michel Bonnivard, Vanessa Champenois, Violaine Noël, Bruno Mourvillier et al. · 2020 · Clinical Infectious Diseases
  86. Plausible Approach for Rapid Detection of SARS-CoV-2 Virus by Magnetic Nanoparticle Based Biosensors
    Md. Aminul Islam, Md. Ziaul Ahsan · 2020 · American Journal of Nanosciences
  87. Deciphering SARS-CoV-2 Virologic and Immunologic Features
    Grégorie Lebeau, Damien Vagner, Étienne Frumence, Franck Ah-Pine, Xavier Guillot, Estelle Nobécourt, Loïc Raffray, Philippe Gasque · 2020 · International Journal of Molecular Sciences
  88. Nucleic acid-based therapy for coronavirus disease 2019
    Ravikant Piyush, Keshav Rajarshi, Aroni Chatterjee, Rajni Khan, Shashikant Ray · 2020 · Heliyon
  89. Recent case studies on the use of ozone to combat coronavirus: Problems and perspectives
    Soumya Nagashri Manjunath, Sakar Mohan, Manmohan Katapadi, R. Geetha Balakrishna · 2020 · Environmental Technology & Innovation
  90. A serological survey of severe acute respiratory syndrome coronavirus 2 in dogs in Wuhan
    Ya Zhao, Yong Ping Yang, Jindong Gao, Kun Lun Huang, Changmin Hu, Xianfeng Hui, Xinglin He, Chengfei Li, Wenxiao Gong, Changjie Lv et al. · 2021 · Transboundary and Emerging Diseases
  91. Virtual high throughput screening: Potential inhibitors for SARS-CoV-2 PLPRO and 3CLPRO proteases
    Dhananjay Jade, Selvaraj Ayyamperumal, Vyshnavi Tallapaneni, Chandrasekar Moola Joghee Nanjan, Sagar Barge, Surender Mohan, Moola Joghee Nanjan · 2021 · European Journal of Pharmacology
  92. Comprehensive analyses of bioinformatics applications in the fight against COVID-19 pandemic
    Lifei Ma, Huiyang Li, Jinping Lan, Xiuqing Hao, Huiying Liu, Xiaoman Wang, Yong Huang · 2021 · Computational Biology and Chemistry
  93. Pediatric COVID-19 patients in South Brazil show abundant viral mRNA and strong specific anti-viral responses
    Tiago Fazolo, Karina Rodrigues Lima, Julia Crispim da Fontoura, Priscila Oliveira de Souza, Gabriel Hilario, Renata Zorzetto, Luiz Rodrigues Júnior, Veridiane Maria Pscheidt, Jayme de Castilhos Ferreira Neto, Alisson Felipe Haubert et al. · 2021 · Nature Communications
  94. Bactrian camels shed large quantities of Middle East respiratory syndrome coronavirus (MERS-CoV) after experimental infection
    Danielle R. Adney, Michael C. Letko, Izabela K. Ragan, Dana P. Scott, Neeltje van Doremalen, Richard A. Bowen, Vincent Jacobus Munster · 2019 · Emerging Microbes & Infections
  95. Cardiac Manifestations of Coronavirus Disease 2019 (COVID-19): A Comprehensive Review
    Faryal Tahir, Taha Bin Arif, Jawad Ahmed, Farheen Malik, Muhammad Usman Khalid · 2020 · Cureus
  96. Early SNS-Based Monitoring System for the COVID-19 Outbreak in Japan: A Population-Level Observational Study
    Daisuke Yoneoka, Takayuki Kawashima, Yuta Tanoue, Shuhei Nomura, Keisuke Ejima, Shoi Shi, Akifumi Eguchi, Toshibumi Taniguchi, Haruka Sakamoto, Hiroyuki Kunishima et al. · 2020 · Journal of Epidemiology
  97. Acupressure therapy and Liu Zi Jue Qigong for pulmonary function and quality of life in patients with severe novel coronavirus pneumonia (COVID-19): a study protocol for a randomized controlled trial
    Shuaipan Zhang, Qingguang Zhu, Chao Zhan, Wei Cheng, Xiao Mingfang, Min Fang, Lei Fang · 2020 · Trials
  98. Drugs against SARS‐CoV ‐2: What do we know about their mode of action?
    Coralie Valle, Baptiste Martin, Franck Touret, Ashleigh Shannon, Bruno Canard, Jean‐Claude Guillemot, Bruno Coutard, Étienne Decroly · 2020 · Reviews in Medical Virology
  99. Opinions on the current pandemic of COVID-19: Use functional food to boost our immune functions
    Bo Han, Ba X. Hoang · 2020 · Journal of Infection and Public Health
  100. Inflammation, Thrombosis, and Destruction: The Three-Headed Cerberus of Trauma- and SARS-CoV-2-Induced ARDS
    Ludmila Lupu, Annette Palmer, Markus Stefan Huber-Lang · 2020 · Frontiers in Immunology